
MRK · NYSE
Merck & Co., Inc.
$145.03 -2.26 (-1.53%)
Company overview
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products for preventive pediatric, adolescent, and adult use. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, health management solutions and services, and digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed healthcare providers such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, physician distributors, veterinarians, and animal producers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NYSE
- Market cap
- $358B
- Employees
- 73,000
- Headquarters
- Rahway, NJ
- Website
- merck.com
- CEO
- Robert Davis
- Listed
- January 13, 1978
- P/E
- 40.74
- Dividend yield
- 2.36%
Company financials
- Revenue
- $65.6B
- Gross profit
- $49.8B
- Operating income
- $18.1B
- EBITDA
- $22.7B
- Net income
- $8.9B
- EPS
- $3.56
- Total assets
- $129B
- Total debt
- $49.1B
- Gross margin
- 75.91%
- Net margin
- 13.62%
- Earnings yield
- 2.45%
Showing FY 2025